Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma
Clinical trial NCT04225039 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04225039
- Sponsor
- University of Pennsylvania
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-23
- Primary completion
- 2022-09-08
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.